-
August 27, 2010
Investors should keep an eye on how much drug companies rely on its top sellers.
-
August 10, 2010
With the first biosimilar approval in over a decade, a major new market for generics could be on the horizon
-
July 05, 2010
Here are some growth-oriented stocks with below-market average P/Es that investors can pick up during this shaky ...
-
June 30, 2010
Amgen is being treated like just another Big Pharma laggard, but analysis suggests there is more growth potential here.
-
June 17, 2010
High-growth biotech stocks are now priced like value plays.
-
June 08, 2010
Amgen hopes for a boost in revenue from their just-approved multi-purpose drug, Prolia.
-
May 26, 2010
ASCO is a major event for the pharmaceutical and biotech industry, and these stocks could shine in the limelight.
-
May 13, 2010
Adaptive design is an idea whose time has come, and investors in biotechs and pharmaceuticals should stand to benefit.
-
April 16, 2010
Look beyond the trees and at the entire Forest, and what you see is a great risk reward opportunity.
-
March 09, 2010
With health care reform ever present in the news, what are the prospects for biotech firms?
-
February 23, 2010
The biotech sector lagged the market in 2009, but it is off to a great start in 2010.
-
January 26, 2010
This company has a pristine capital structure and a stockpile of cash, but the best part is that its stock is cheap.
-
January 25, 2010
Apple will be the most closely watched company to report quarterly earnings January 25, but several other big names ...
-
October 16, 2009
Biotech stocks traditionally fare well through recessions. We'll see if that holds true.
-
July 28, 2009
A look at the top-selling drugs finds that a few that make more of a difference to the company's bottom line than ...
-
July 01, 2009
We take a look at the stock repurchase report from S&P, to see what is signals for the economy.
-
June 03, 2009
GM and Citigroup being removed from the DJIA should cause investors to focus on diversification.
-
April 30, 2009
John Calamos, the father of convertible investing, moderated a panel on convertible bonds at the Milken Global ...
-
March 04, 2009
The DJIA is sure to be rebalanced over the next year as some members teeter on bankruptcy or face falling from the ...
-
February 16, 2009
This company's IPO of its Mead Johnson unit will serve as a litmus test for the health of the 2009 equities market.
